Business
Press Release Dec 19 2022
Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 19, 2022, titled "Dr. Reddy s successfully completes Phase 1 study ofDRL_TC, a proposed biosimilar of tocilizumab".
About this update from Dr. Reddy's Laboratories Ltd.
[{"type":"text","content":" Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 19, 2022, titled \"Dr. Reddy s successfully completes Phase 1 study ofDRL_TC, a proposed biosimilar of tocilizumab\". View Attachment","length":367,"tagName":"div"}]